Beijing Strong Biotechnologies Inc - Asset Resilience Ratio

Latest as of June 2025: 3.00%

Beijing Strong Biotechnologies Inc (300406) has an Asset Resilience Ratio of 3.00% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Beijing Strong Biotechnologies Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥163.21 Million

≈ $23.88 Million USD Cash + Short-term Investments

Total Assets

CN¥5.44 Billion

≈ $796.34 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2018–2020)

This chart shows how Beijing Strong Biotechnologies Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Beijing Strong Biotechnologies Inc (300406) total assets.

Liquid Assets Composition Over Time

This chart breaks down Beijing Strong Biotechnologies Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore long-term investment intensity of Beijing Strong Biotechnologies Inc to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥163.21 Million	3.0%
Total Liquid Assets	CN¥163.21 Million	3.00%

Asset Resilience Insights

Limited Liquidity: Beijing Strong Biotechnologies Inc maintains only 3.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Beijing Strong Biotechnologies Inc Industry Peers by Asset Resilience Ratio

Compare Beijing Strong Biotechnologies Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
LONZA GROUP UNSP.ADR 1/10 F:LO3A	Diagnostics & Research	3.04%
Healius Ltd AU:HLS	Diagnostics & Research	0.06%
Eurofins-Cerep SA PA:ALECR	Diagnostics & Research	13.42%
Gencurix Inc KQ:229000	Diagnostics & Research	4.01%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%

Annual Asset Resilience Ratio for Beijing Strong Biotechnologies Inc (2018–2020)

The table below shows the annual Asset Resilience Ratio data for Beijing Strong Biotechnologies Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2020-12-31	0.13%	CN¥5.15 Million ≈ $752.88K	CN¥3.96 Billion ≈ $580.01 Million	-6.31pp
2018-12-31	6.44%	CN¥120.00 Million ≈ $17.56 Million	CN¥1.86 Billion ≈ $272.87 Million	--

pp = percentage points

About Beijing Strong Biotechnologies Inc

SHE:300406 China Diagnostics & Research

Market Cap

$978.07 Million

CN¥6.68 Billion CNY

Market Cap Rank

#9061 Global

#2238 in China

Share Price

CN¥11.40

Change (1 day)

+1.06%

52-Week Range

CN¥10.82 - CN¥15.23

All Time High

CN¥24.76